Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease

Journal of Human Genetics

Volumn 55, Issue 12, 2010, Pages 779-784

  Shimizu, Chisato ^a   Matsubara, Tomoyo ^b   Onouchi, Yoshihiro ^c   Jain, Sonia ^a   Sun, Shelly ^a   Nievergelt, Caroline M ^d   Shike, Hiroko ^a   Brophy, Victoria H ^e   Takegawa, Tsuyoshi ^f   Furukawa, Susumu ^f   Akagi, Teiji ^g   Newburger, Jane W ^h   Baker, Annette L ^h   Burgner, David ^i,j   Hibberd, Martin L ^k   Davila, Sonia ^k   Levin, Michael ^l   Mamtani, Manju ^m   He, Weijing ^m   Ahuja, Sunil K ^m   Burns, Jane C ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JUNTENDO UNIVERSITY   (Japan)

^c RIKEN   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ROCHE MOLECULAR SYSTEMS   (United States)

^f YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^h BOSTON CHILDREN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^j ROYAL CHILDREN'S HOSPITAL   (Australia)

^k GENOME INSTITUTE OF SINGAPORE   (Singapore)

^l IMPERIAL COLLEGE LONDON   (United Kingdom)

^m UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

more..

Author keywords

coronary artery aneurysm; haplotype; Kawasaki disease; matrix metalloproteinase

Indexed keywords

COLLAGENASE 3; ELASTASE; GENE PRODUCT; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; STROMELYSIN;

ARTICLE; CHROMOSOME 11Q; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENZYME ACTIVITY; ETHNICITY; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENE LOCUS; GENE STRUCTURE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RISK ASSESSMENT;

CASE-CONTROL STUDIES; CHILD; CORONARY ANEURYSM; FEMALE; HAPLOTYPES; HUMANS; MALE; MATRIX METALLOPROTEINASES; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78650563566     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2010.109     Document Type: Article

References (29)

1. Takahashi, K., Oharaseki, T., Naoe, S., Wakayama, M. & Yokouchi, Y. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int. 47, 305-310 (2005). (Pubitemid 40827508)
2. Inamo, Y., Harada, K., Okuni, M., Kimoto, K., Takeuchi, S. & Sakurabayashi, I. Immunoreactive polymorphonuclear leukocyte elastase in complex with alpha 1-antitrypsin in Kawasaki disease. Acta Paediatr Jpn. 29, 202-205 (1987). (Pubitemid 17090601)
3. Biezeveld, M. H., van Mierlo, G., Lutter, R., Kuipers, I. M., Dekker, T., Hack, C. E. et al. Sustained activation of neutrophils in the course of Kawasaki disease: An association with matrix metalloproteinases. Clin Exp Immunol. 141, 183-188 (2005). (Pubitemid 40904656)
4. Shapiro, S. D. Matrix metalloproteinase degradation of extracellular matrix: Biological consequences. Curr Opin Cell Biol. 10, 602-608 (1998). (Pubitemid 28477018)
5. Manicone, A. M. & McGuire, J. K. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol. 19, 34-41 (2008).
6. Burns, J. C. & Glode, M. P. Kawasaki syndrome. Lancet. 364, 533-544 (2004).
7. Burgner, D., Davila, S., Breunis, W. B., Ng, S. B., Li, Y., Bonnard, C. et al. A genomewide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS genetics. 5, e1000319 (2009).
8. Burns, J. C., Shimizu, C., Gonzalez, E., Kulkarni, H., Patel, S., Shike, H. et al. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J Infect Dis. 192, 344-349 (2005). (Pubitemid 40993406)
9. Burns, J. C., Shimizu, C., Shike, H., Newburger, J. W., Sundel, R. P., Baker, A. L. et al. Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun. 6, 438-444 (2005). (Pubitemid 43090520)
10. Onouchi, Y., Gunji, T., Burns, J. C., Shimizu, C., Newburger, J. W., Yashiro, M. et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet. 40, 35-42 (2008).
11. Onouchi, Y., Tamari, M., Takahashi, A., Tsunoda, T., Yashiro, M., Nakamura, Y. et al. A genomewide linkage analysis of Kawasaki disease: Evidence for linkage to chromosome 12. J Hum Genet. 52, 179-190 (2007). (Pubitemid 46185112)
12. Aziz, F. & Kuivaniemi, H. Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm. Ann Vasc Surg. 21, 392-401 (2007). (Pubitemid 46678660)
13. Thompson, R. W. & Parks, W. C. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann NY Acad Sci. 800, 157-174 (1996). (Pubitemid 27028953)
14. Newburger, J. W., Takahashi, M., Gerber, M. A., Gewitz, M. H., Tani, L. Y., Burns, J. C. et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 110, 2747-2771 (2004). (Pubitemid 39453026)
15. Disease, R.C.o.K. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease (Ministry of Health and Welfare, Tokyo, Japan, 1984).
16. Jormsjo, S., Whatling, C., Walter, D. H., Zeiher, A. M., Hamsten, A. & Eriksson, P. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 21, 1834-1839 (2001). (Pubitemid 34219789)
17. Jormsjo, S., Ye, S., Moritz, J., Walter, D. H., Dimmeler, S., Zeiher, A. M. et al. Allelespecific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ Res. 86, 998-1003 (2000). (Pubitemid 30324313)
18. Rutter, J. L., Mitchell, T. I., Buttice, G., Meyers, J., Gusella, J. F., Ozelius, L. J. et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 58, 5321-5325 (1998). (Pubitemid 28551108)
19. Ye, S., Eriksson, P., Hamsten, A., Kurkinen, M., Humphries, S. E. & Henney, A. M. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem. 271, 13055-13060 (1996). (Pubitemid 26175880)
20. Yoon, S., Kuivaniemi, H., Gatalica, Z., Olson, J. M., Buttice, G., Ye, S. et al. MMP13 promoter polymorphism is associated with atherosclerosis in the abdominal aorta of young black males. Matrix Biol. 21, 487-498 (2002). (Pubitemid 35248274)
21. Haq, I., Chappell, S., Johnson, S. R., Lotya, J., Daly, L., Morgan, K. et al. Association of MMP-2 polymorphisms with severe and very severe COPD: A case control study of MMPs-1, 9 and 12 in a European population. BMC Medical Genetics. 11, 7.
22. Joos, L., He, J. Q., Shepherdson, M. B., Connett, J. E., Anthonisen, N. R., Pare, P. D. et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum. Mol Genetics. 11, 569-576 (2002). (Pubitemid 34257493)
23. Ricketts, C., Zeegers, M. P., Lubinski, J. & Maher, E. R. Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinoma. PLoS One. 4, e6037 (2009).
24. Dempster, A., Laird, N. & Rubin, D. Likelihood from incomplete data via the EM algorithm. J. Royal Stat. Soc. Series B. 39, 1-38 (1977).
25. Sinnwell, J. P. & Schaid, D. J. haplo.stats: Statistical analysis of haplotypes with traits and covariates when linkage phase is ambiguous R package version 1.2.2., (2005).
26. Hautamaki, R. D., Kobayashi, D. K., Senior, R. M. & Shapiro, S. D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science. 277, 2002-2004 (1997).
27. Matsuyama, A., Sakai, N., Ishigami, M., Hiraoka, H., Kashine, S., Hirata, A. et al. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation. 08, 1469-1473 (2003). (Pubitemid 37176453)
28. Park, J. A., Shin, K. S. & Kim, Y. W. Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease. J Korean Med Sci. 20, 607-611 (2005). (Pubitemid 41265139)
29. Ikeda, K., Ihara, K., Yamaguchi, K., Muneuchi, J., Ohno, T., Mizuno, Y. et al. Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease. Pediatr Res. 3, 182-185 (2008). (Pubitemid 351831459)